Endotoxemia, inflammation, and atrial fibrillation

Area of Science:

• Cardiology
• Immunology
• Internal Medicine

Background:

• Emerging evidence suggests a link between systemic inflammation and atrial fibrillation (AF).
• Lipopolysaccharide (LPS) infusion is a standard model for studying inflammatory responses.
• The hypothesis posits that LPS-induced inflammation may increase AF susceptibility.

Purpose of the Study:

• To investigate whether LPS challenge, a model of acute inflammation, increases the risk of new-onset atrial fibrillation (AF).
• To assess the impact of experimental inflammation on AF development in a healthy, low-risk population.

Main Methods:

• A post hoc analysis of prospective data from 652 healthy men without prior AF history.
• Subjects received an LPS challenge, followed by continuous cardiac monitoring and rhythm assessments at 24 hours and 7 days.
• Inflammatory markers (hs-CRP, IL-6, TNF-α, neutrophils) and temperature were measured post-challenge.

Main Results:

• LPS challenge induced significant increases in hs-CRP, IL-6, TNF-α, and neutrophil counts (p<0.0001).
• An average temperature increase of 1.1°C was observed.
• No cases of new-onset AF were detected in any subjects during the monitoring period.

Conclusions:

• Experimental LPS challenge effectively simulates acute systemic inflammation.
• Despite significant inflammatory markers, LPS challenge did not precipitate new-onset AF in young, healthy men.
• This suggests that acute inflammation alone may not be sufficient to trigger AF in a low-risk population.